Asian Journal of Andrology

INVITED PERSPECTIVE
Year
: 2016  |  Volume : 18  |  Issue : 4  |  Page : 505--508

Personalized prostate cancer care: from screening to treatment


Carly A Conran, Charles B Brendler, Jianfeng Xu 
 Program for Personalized Cancer Care, NorthShore University HealthSystem, 1001 University Place, Evanston, IL 60201, USA

Correspondence Address:
Dr. Charles B Brendler
Program for Personalized Cancer Care, NorthShore University HealthSystem, 1001 University Place, Evanston, IL 60201
USA

Unprecedented progress has been made in genomic personalized medicine in the last several years, allowing for more individualized healthcare assessments and recommendations than ever before. However, most of this progress in prostate cancer (PCa) care has focused on developing and selecting therapies for late-stage disease. To address this issue of limited focus, we propose a model for incorporating genomic-based personalized medicine into all levels of PCa care, from prevention and screening to diagnosis, and ultimately to the treatment of both early-stage and late-stage cancers. We have termed this strategy the «DQ»Pyramid Model«DQ» of personalized cancer care. In this perspective paper, our objective is to demonstrate the potential application of the Pyramid Model to PCa care. This proactive and comprehensive personalized cancer care approach has the potential to achieve three important medical goals: reducing mortality, improving quality of life and decreasing both individual and societal healthcare costs.


How to cite this article:
Conran CA, Brendler CB, Xu J. Personalized prostate cancer care: from screening to treatment.Asian J Androl 2016;18:505-508


How to cite this URL:
Conran CA, Brendler CB, Xu J. Personalized prostate cancer care: from screening to treatment. Asian J Androl [serial online] 2016 [cited 2021 Sep 25 ];18:505-508
Available from: https://www.ajandrology.com/article.asp?issn=1008-682X;year=2016;volume=18;issue=4;spage=505;epage=508;aulast=Conran;type=0